AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
68 hedge funds and large institutions have $41.3M invested in AVEO Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 16 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
3% less funds holding
Funds holding: 70 → 68 (-2)
31% less capital invested
Capital invested by funds: $60M → $41.3M (-$18.8M)
44% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 25
79% less call options, than puts
Call options by funds: $6K | Put options by funds: $28K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$898K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$470K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
+$432K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$401K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$362K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$2.51M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$2.2M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.65M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.6M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.06M |
AVEO Hedge Fund Activity: Q1 2014 in Review
68 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2014, worth a combined $41.3M — down 31% from $60M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of AVEO and 15 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 14 added.
The largest buyer was SAC Capital Advisors, opening a new position worth an estimated $898K. The largest seller was MPM Asset Management, exiting entirely with an estimated $2.51M sold.
- 68 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2014, down from 70 in Q4 2013.
- Funds reported $41.3M of AVEO Pharmaceuticals, Inc. stock for Q1 2014, down 31% quarter-over-quarter.
- 15 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2014 and 16 closed out, a net change of -1 holder.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2014 was SAC Capital Advisors, an estimated $898K added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q1 2014 was MPM Asset Management, an estimated $2.51M sold.
Based on aggregated 13F filings for Q1 2014.